RESET THERAPEUTICS INC has a total of 31 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are CHEMOCENTRYX INC, SERENEX INC and HELICON THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | China | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Argentina | 2 | |
#5 | Canada | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 2 | |
#9 | New Zealand | 2 | |
#10 | Singapore | 2 | |
#11 | Taiwan | 2 | |
#12 | Brazil | 1 | |
#13 | Israel | 1 | |
#14 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Bersot Ross | 24 |
#2 | Humphries Paul | 24 |
#3 | Ross Bersot | 5 |
#4 | Paul Humphries | 5 |
#5 | Takahashi Joseph S | 1 |
#6 | Kay Steve A | 1 |
Publication | Filing date | Title |
---|---|---|
MX2016013105A | Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators. | |
CN104640856A | Carbazole-containing sulfonamides as cryptochrome modulators | |
WO2011112167A1 | Compositions and methods for diabetes treatment |